NH vs NIPPON INDIA MULTI CAP FUND (Multi Cap Fund - An Open Ended Equity Scheme Investing Across Large Cap, Mid Cap, Small Cap Stocks)

Portfolio Overlap Analysis · Nippon vs Nippon

5.5%
Low Overlap
9 common stocks · Rank #27402 of 28,292 pairs

Common Holdings (9)

StockWt% in NHWt% in NIPPON INDIA MULTI CAP FUND (MOverlap
Lupin Limited
Pharmaceuticals & Biotechnology
1.14%6.65%1.14%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
0.84%9.71%0.84%
Cipla Limited
Pharmaceuticals & Biotechnology
0.63%9.04%0.63%
Abbott India Limited
Pharmaceuticals & Biotechnology
0.57%1.65%0.57%
Gland Pharma Limited
Pharmaceuticals & Biotechnology
0.53%1.73%0.53%
Ajanta Pharma Limited
Pharmaceuticals & Biotechnology
0.48%1.50%0.48%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
0.46%3.93%0.46%
Biocon Limited
Pharmaceuticals & Biotechnology
0.46%3.32%0.46%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
0.39%2.53%0.39%

Unique to NH

  • Sun Pharmaceutical Industries Limited21.93%
  • Dr. Reddy's Laboratories Limited9.35%
  • Torrent Pharmaceuticals Limited5.40%
  • Laurus Labs Limited4.98%
  • Aurobindo Pharma Limited4.07%
  • Glenmark Pharmaceuticals Limited3.84%

Unique to NIPPON INDIA MULTI CAP FUND (M

  • HDFC Bank Limited5.69%
  • ICICI Bank Limited4.37%
  • Axis Bank Limited3.85%
  • GE Vernova T&D India Limited3.04%
  • Infosys Limited2.54%
  • Max Financial Services Limited2.48%
  • NTPC Limited2.24%
  • Reliance Industries Limited2.21%
  • Linde India Limited2.02%
  • Larsen & Toubro Limited1.93%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
5.5% (9)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for NH

More comparisons for NIPPON INDIA MULTI CAP FUND (M

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.